Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer
Publication date: Available online 1 June 2021Source: Pharmacological ResearchAuthor(s): Xue-ting Cai, Jing Miao, Rong-wei Sun, Sai-nan Wang, Miguel Angel Molina-Vila, Imane Chaib, Rafael Rosell, Peng Cao
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Lung Cancer | Non-Small Cell Lung Cancer